drugset / Trial / NCT05217537
Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the pharmacokinetics of a single dose of intravenous or oral omadacycline in children and adolescents with suspected or confirmed bacterial infections.
Timeline
- Start
- 2022-04-06
- Primary completion
- 2025-02-27
- Completion
- 2025-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omadacycline | Small molecule | 100 mg | Intravenous |
| Subject | Omadacycline | Small molecule | 300 mg | Intravenous |